Opportunity Overview
Specific items include:
o TaqMan probes are specialized, dual-labeled DNA oligonucleotides used in quantitative real-time PCR (qPCR) to detect and measure specific DNA sequences. They feature a 5 fluorescent reporter dye and a 3 quencher, which suppresses fluorescence until Taq DNA polymerase cleaves the probe during amplification, releasing a measurable signal proportional to the target DNA amount.
o FAM, VIC and CY5 are the 5 markers respectably.
o QSY, TAM, MGB, And QSY2 are all 3 markers respectably.
o The probes can be used to perform Multiplex up to five/six targets
o TAM for Multiplex up to 2 targets, Ideal for maintaining consistency in projects using legacy TAMRA probe designs, Available with FAM, VIC, and TET dyes
o MGB for multiplexing up to five targets with FAM, VIC, ABY, JUN, and Cyanine 5 (Cy5)
o QSY for multiplexing up to four targets with ABY, JUN, FAM, and VIC dyes
o QSY2 for 5th and 6th target multiplexing with Cyanine 5 (Cy5) and Cyanine 5.5 (Cy5.5) dyes
The NAICS code for this action is 325414. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Naval Medical Research Center |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| NAICS | 325414 |
| PSC | 6550 |
| Published | May 13, 2026 |
| Procurement stage | Request for Proposal (RFP) |
| Closed | May 13, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Browse Similar Open Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.